Immune-inflammatory-fibrinogen score as a novel prognostic biomarker in patients with gastric cancer undergoing radical gastrectomy: a multicenter study
GastroenterologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- World journal of surgical oncology
- Publicado em
- 1 jun 2026
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Immune-inflammatory-fibrinogen score as a novel prognostic biomarker in patients with gastric cancer undergoing radical gastrectomy: a multicenter study
Wei Zhao, Qing Zhong, Bao-Long Li, Cai-Ming Weng, Hao-Xiang Zhang, Gang Wang, Zhi-Quan Zhang, Ying-Xin Wu, Dong Wu, Jun-Yu Chen et al.
Descritores MeSH
- Gastrectomy
- Fibrinogen
- Stomach Neoplasms
- Biomarkers, Tumor
- Inflammation
- Nomograms
- Neoplasm Staging
- Prognosis
- Retrospective Studies
- Survival Rate
Veja também
Estudos relacionados
- Psychological Interventions and Sleep Improvement for Patients with Gastric Cancer: Effects on Immune Function, Inflammation, and Tumor Progression-A Randomized Controlled Trial
- Clinicopathological Factors Affecting Stomach Preservation Following Laparoscopic Sentinel Node Navigation Surgery in Patients with Early Gastric Cancer: A Secondary Analysis of the Multicenter Randomized Phase III SENORITA Trial
- Long-Term Effects of Oral Nutritional Supplements After Gastrectomy for Gastric Cancer: A Survival Analysis from a Multicenter, Open-Label, Randomized Controlled Trial
- Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis